Finance

Beta
Lists
102460:KRX
Reyon Pharmaceutical Co Ltd
â‚©9,900.00
0.00%
(0.00) 1D
Jun 12, 3:30:20 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 102460...
Open
â‚©9,900
High
â‚©10,050
Low
â‚©9,630
Mkt. cap
184.01B
Avg. vol.
148.26K
Volume
0.00
52-wk high
â‚©14,430
52-wk low
â‚©9,100
EPS
-â‚©2,213
Shares outstanding
18.59M
No. of employees
440
Open
â‚©9,900
High
â‚©10,050
Low
â‚©9,630
Mkt. cap
184.01B
Avg. vol.
148.26K
Volume
0.00
52-wk high
â‚©14,430
52-wk low
â‚©9,100
EPS
-â‚©2,213
Shares outstanding
18.59M
No. of employees
440
News stories
From sources across the web
About Reyon Pharmaceutical Co Ltd
CEO-
Employees440
Founded1955
Headquarters-
SectorPharmaceutical industry
Websitereyonpharm.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
37.69B
37.58B
33.90B
36.05B
Cost of goods sold
31.95B
27.67B
25.88B
26.48B
Cost of revenue
31.95B
27.67B
25.88B
26.48B
Research and development expenses
596.40M
1.85B
632.62M
973.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.90B
14.06B
15.03B
13.95B
Operating expense
16.87B
17.31B
17.07B
16.34B
Total operating expenses
48.82B
44.99B
42.95B
42.82B
Operating income
-11.13B
-7.40B
-9.05B
-6.77B
Other non operating income
2.19B
6.21B
517.58M
124.38M
EBT including unusual items
-12.53B
-3.18B
-9.77B
-11.17B
EBT excluding unusual items
-12.53B
-3.18B
-10.71B
-11.16B
Income tax expense
618.54M
680.90M
3.07B
-432.72M
Effective tax rate
-4.94%
-21.40%
-31.37%
3.87%
Other operating expenses
209.99M
248.73M
252.68M
250.24M
Net income
-13.15B
-3.86B
-12.84B
-10.74B
Net profit margin
-34.88%
-10.28%
-37.88%
-29.78%
Earnings per share
-
-
-
-
Interest and investment income
21.18M
13.90M
179.27M
12.92M
Interest expense
-3.24B
-3.31B
-3.39B
-3.49B
Net interest expenses
-3.22B
-3.30B
-3.21B
-3.47B
Depreciation and amortization charges
1.18B
1.17B
1.16B
1.16B
EBITDA
-3.21B
535.77M
-1.05B
1.24B
Gain or loss from assets sale
-
1.84M
-
7.70M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer